TScan Therapeutics financial statements

티스캔 테라퓨틱스NASDAQ:TCRX · Nasdaq · Healthcare · sector #17
$0.2754-6.74%
2026-10-06 close

TScan Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $3M. 2024 operating profit was −$136M.

Reported results

TScan Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy